Evidence map›Paper›PMID 42270621›Full record

ArticleNature communications2026

The distinct trimeric structure of the immunodominant chlamydial antigen Major Outer Membrane Protein.

Yirui Guo, Megan L Shelby, Patrik D'haeseleer, Sukumar Pal, Anatoli Slepenkin, Beverly V Robinson, Zbyszek Otwinowski, Brent W Segelke, Matthew A Coleman, Dominika Borek and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yirui Guo *Department of Biophysics, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0001-7705-5454
Megan L Shelby *Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Patrik D'haeseleerBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Sukumar PalDepartment of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA, USA.
Anatoli SlepenkinDepartment of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA, USA.
Beverly V RobinsonBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.ORCID 0000-0003-0497-9634
Zbyszek OtwinowskiDepartment of Biophysics, UT Southwestern Medical Center, Dallas, TX, USA.
Brent W SegelkeBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.ORCID 0000-0003-3358-5028
Matthew A ColemanBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.ORCID 0000-0003-1389-4018
Dominika BorekDepartment of Biophysics, UT Southwestern Medical Center, Dallas, TX, USA. dominika.borek@utsouthwestern.edu.ORCID 0000-0002-4321-6253
Luis M de la MazaDepartment of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA, USA. lmdelama@uci.edu.ORCID 0000-0002-6183-7053

Funding

Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatisU19AI144184 · NIAID · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI D'HAESELEER, PATRIK · 2019 to 2023
$10.0M
IMMUNOPATHOLOGY OF TUBAL INFERTILITYR01AI032248 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI DE LA MAZA, LUIS M · 1993 to 2007
$2.6M
From complex data to complex structures: new methods for structural biologyR35GM145365 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ZBYSZEK OTWINOWSKI · 2022 to 2026
$2.3M
NEUTRALIZING EPITOPES OF CHLAMYDIA TRACHOMATISR01AI030499 · NIAID · UNIVERSITY OF CALIFORNIA IRVINE · PI PETERSON, ELLENA MARIE · 1991 to 1997
–
ODCDC CDC HHS 75N93022C00035U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI030499U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI032248U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI144184U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM145365
6 · The paper itself

Abstract

The chlamydial Major Outer Membrane Protein (MOMP) is a promising subunit vaccine candidate due to its abundance in the outer membrane (OM), the presence of four surface-exposed variable domains (VDs) containing neutralizing and serotyping epitopes, and confirmed T-cell epitopes located in its constant domains (CDs). However, recombinant and denatured forms of MOMP have failed to elicit immune responses comparable to native preparations, indicating that conformation is critical for immunogenicity. Here, we present two cryo-EM structures of native Chlamydia muridarum MOMP, isolated from infectious elementary bodies (EBs). EB MOMP forms a distinct trimer with a stem of three narrow, non-permeable β-barrels and an extracellular, folded antigenic cap that displays VDs. In complex with a neutralizing Fab fragment of a conformational antibody, the cap undergoes structural reorganization that shows how epitope presentation is modulated by immune engagement. These structures reveal the molecular basis of MOMP's serovar specificity and provide a template for structure-based vaccine design.

Indexed as

Antigens, BacterialBacterial Outer Membrane ProteinsChlamydia muridarumImmunodominant EpitopesCryoelectron MicroscopyModels, MolecularProtein Subunit VaccinesAntigens, BacterialBacterial Outer Membrane ProteinsImmunodominant EpitopesProtein Subunit Vaccines

Identifiers

PMID42270621
PMCPMC13254160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.